TY - JOUR
T1 - Lifetime costs of the top five cancers in Taiwan
AU - Lang, Hui Chu
AU - Wu, Shi Liang
N1 - Funding Information:
This study was funded by Taiwan National Health Research Institute (NHRI-EX94-9007PC). I would like to especially thank Jaw-Ching Wu for the SAS programming.
PY - 2012/6
Y1 - 2012/6
N2 - The purpose of this study was to determine cancer-related medical care costs for long-term cancer care costs of breast, cervical, liver, lung, and colorectal cancer. Data were sourced from Taipei Veterans General Hospital cancer registry and claim data during 1999-2002. Besides, claimed data from National Health Insurance were used to match the comparison group. To estimate lifetime cost (10 years), the whole disease process was divided into initial, continuing, and terminal three phases. The expected lifetime cost of a specific cancer patient was estimated by incorporating the average phase-specific costs with the survival rate and mortality rate. The undiscounted average lifetime costs (10 years) for lung cancer, colorectal cancer, liver cancer, cervical cancer, and breast cancer were NT$448,371 (1USD=NTD33), NT$584,985, NT$351,222, NT$511,563, and NT$674,282 (in 2002 NTD), respectively. The aggregate lifetime cost of cancer is useful for health policymaking and clinical decision-making.
AB - The purpose of this study was to determine cancer-related medical care costs for long-term cancer care costs of breast, cervical, liver, lung, and colorectal cancer. Data were sourced from Taipei Veterans General Hospital cancer registry and claim data during 1999-2002. Besides, claimed data from National Health Insurance were used to match the comparison group. To estimate lifetime cost (10 years), the whole disease process was divided into initial, continuing, and terminal three phases. The expected lifetime cost of a specific cancer patient was estimated by incorporating the average phase-specific costs with the survival rate and mortality rate. The undiscounted average lifetime costs (10 years) for lung cancer, colorectal cancer, liver cancer, cervical cancer, and breast cancer were NT$448,371 (1USD=NTD33), NT$584,985, NT$351,222, NT$511,563, and NT$674,282 (in 2002 NTD), respectively. The aggregate lifetime cost of cancer is useful for health policymaking and clinical decision-making.
KW - Cancer
KW - Cost
KW - Incidence-based
KW - Lifetime cost
KW - Long-term cost
UR - http://www.scopus.com/inward/record.url?scp=84861195592&partnerID=8YFLogxK
U2 - 10.1007/s10198-011-0307-1
DO - 10.1007/s10198-011-0307-1
M3 - Article
C2 - 21442437
AN - SCOPUS:84861195592
SN - 1618-7598
VL - 13
SP - 347
EP - 353
JO - European Journal of Health Economics
JF - European Journal of Health Economics
IS - 3
ER -